Infinity Pharma (INFI) Tops Q3 EPS by 47c
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Infinity Pharma (NASDAQ: INFI) reported Q3 EPS of ($0.39), $0.47 better than the analyst estimate of ($0.86).
At September, 2016, Infinity had total cash, cash equivalents and available-for-sale securities of $112.3 million, compared to $146.4 million at June 30, 2016.
For earnings history and earnings-related data on Infinity Pharma (INFI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald's (MCD) Tops Q4 EPS by 3c
- Community Bank System (CBU) Tops Q1 EPS by 1c
- Expect Facebook (FB) To Show Strong Q4 Report, Monitor For Guidance On Expenses - Goldman Sachs
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!